Implications of 4S evidence on baseline lipid levels-Reference-Cited by-同舟云学术

Implications of 4S evidence on baseline lipid levels

Published:1995-07 Issue:8968 Volume:346 Page:181-182
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Durrington P.N.,Ravnskov Uffe,Jacobson TerryA.

Publisher

Elsevier BV

Subject

General Medicine

Reference11 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994

2. Hyperlipidaemia: diagnosis and management;Durrington,1994

3. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid;Carlson;Acta Med Scand,1988

4. Report on a co-operative trial in the primary prevention of ischaemic heart disease using clofibrate;Committee of Principal Investigators;Br Heart J,1978

5. The Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease;Frick;N Engl J Med,1987

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet;Current Opinion in Endocrinology, Diabetes & Obesity;2022-08-04

2. Response to Ravnskov et al. on saturated fat and CHD;British Journal of Nutrition;2011-12-13

3. Reply to U Ravnskov;The American Journal of Clinical Nutrition;2006-12-01

4. A hypothesis out-of-date;Journal of Clinical Epidemiology;2002-11

5. The Questionable Role of Saturated and Polyunsaturated Fatty Acids in Cardiovascular Disease;Journal of Clinical Epidemiology;1998-06